D. Western Therapeutics Institute, Inc. (TYO:4576)
Japan flag Japan · Delayed Price · Currency is JPY
126.00
-2.00 (-1.56%)
Jun 13, 2025, 3:30 PM JST

TYO:4576 Revenue

D. Western Therapeutics Institute had revenue of 96.76M JPY in the quarter ending March 31, 2025, a decrease of -6.96%. This brings the company's revenue in the last twelve months to 463.52M, up 4.87% year-over-year. In the year 2024, D. Western Therapeutics Institute had annual revenue of 471.00M with 10.05% growth.

Revenue (ttm)
463.52M
Revenue Growth
+4.87%
P/S Ratio
12.31
Revenue / Employee
22.07M
Employees
21
Market Cap
5.70B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024471.00M43.00M10.05%
Dec 31, 2023428.00M-20.00M-4.46%
Dec 31, 2022448.00M34.00M8.21%
Dec 31, 2021414.00M59.00M16.62%
Dec 31, 2020355.00M-225.00M-38.79%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,222.12B
Takeda Pharmaceutical Company 4,581.55B
Daiichi Sankyo Company 1,886.26B
HOYA Corporation 869.37B
Terumo 1,036.17B
Otsuka Holdings 2,393.18B
Astellas Pharma 1,912.32B
Olympus 997.33B
Revenue Rankings